Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space
This article was originally published in The Tan Sheet
Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists
You may also be interested in...
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
Perrigo Grows Into Adjacent Infant Formula Category With PBM Acquisition
Perrigo takes the next step toward becoming a one-stop shop for private-label consumer health products with its $808 million acquisition of infant formula and baby food firm PBM Holdings Inc
Caremark Hopes OTC Alternatives To Rx Drugs Will Lead To Savings In 2006
Pharmacy benefit manager Caremark will look to over-the-counter substitutes for branded prescription therapies to generate savings in 2006, according to CEO Mac Crawford